Loading chat...
WV HB5553
Bill
Status
2/16/2026
Primary Sponsor
Josh Holstein
Click for details
AI Summary
-
Authorizes the Public Employees Insurance Agency (PEIA) and Department of Human Services to voluntarily participate in federal prescription drug pricing programs, including most-favored-nation and international reference pricing models
-
Permits participation through direct purchasing agreements with pharmaceutical manufacturers, federally negotiated pricing arrangements, or utilization of federal benchmark/ceiling prices for reimbursement
-
Requires participation only if the responsible agency determines it serves the state's best financial interest and does not reduce beneficiary access to medically necessary drugs
-
Preserves state authority to administer its own pharmacy benefits and does not require adoption of a federal formulary
-
Mandates annual reports to the Joint Committee on Government and Finance by December 1 detailing program participation, estimated cost savings, and any access or administrative issues identified
Legislative Description
Relating to participation in federal prescription drug pricing programs.
Health
Last Action
To House Health and Human Resources
2/16/2026